SJR 34
5 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Browse all held record sources
Zoom to read. Drag to explore. Select a connection.
SJR 34
Relative to Medicare coverage of oral cancer drugs
California · Introduced
Every link on this map
The same connections as a table, with the reason each one is here.
| Astrazeneca Pharmaceuticals, LP | Lobbied on it | Astrazeneca Pharmaceuticals, LP named SJR 34 in 2 lobbying reports. | 2 reports |
| Novartis Services, Inc | Lobbied on it | Novartis Services, Inc named SJR 34 in 2 lobbying reports. | 2 reports |
| American Cancer Society, California Division, Inc. | Lobbied on it | American Cancer Society, California Division, Inc. named SJR 34 in 1 lobbying report. | 1 report |
| Genentech, Inc., A Member of the Roche Group | Lobbied on it | Genentech, Inc., A Member of the Roche Group named SJR 34 in 1 lobbying report. | 1 report |
| Relative to Medicare coverage of oral cancer drugs. | Source records | SJR 34 has an explicit source reference to Relative to Medicare coverage of oral cancer drugs.. | None |
In the news
Reporting about the selected subject. Articles are context and do not establish a connection on this map.
Loading coverage…